MYLAN 810 MYLAN 810 (Hydrochlorothiazide 12.5 mg)
Pill imprint MYLAN 810 MYLAN 810 has been identified as Hydrochlorothiazide 12.5 mg.
Hydrochlorothiazide is used in the treatment of high blood pressure; edema; nephrocalcinosis; diabetes insipidus; osteoporosis and belongs to the drug class thiazide diuretics. There is no proven risk in humans during pregnancy. Hydrochlorothiazide 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 12.5 mg
- 12.00 mm
- Prescription only
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0776||UDL Laboratories Inc|
|54569-5236||A-S Medication Solutions, LLC (repackager)|
|54868-4438||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about hydrochlorothiazide
- Hydrochlorothiazide capsules
- Hydrochlorothiazide solution
- Hydrochlorothiazide (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.